Characterisation of <i>in vitro</i> resistance selection against second-/last-line antibiotics in methicillin-resistant <i>Staphylococcus aureus</i> ATCC 43300 strain
<i>In vitro</i> selection against VAN, DAP or LZD resulted in the acquisition of mutations similar to those correlated with clinical resistance, including the associated phenotypic alterations.
Authors
- Ian R. Monk (ORCID: https://orcid.org/0000-0001-6982-8074)
- Miranda E. Pitt (ORCID: https://orcid.org/0000-0002-8255-4036)
- Angela M. Kavanagh
- Devika Ganesamoorthy (ORCID: https://orcid.org/0000-0001-8149-6703)
- Anggia Prasetyoputri (ORCID: https://orcid.org/0000-0002-9543-8253)
- Lachlan Coin (ORCID: https://orcid.org/0000-0002-4300-455X)
- Timothy P. Stinear (ORCID: https://orcid.org/0000-0003-0150-123X)
- Mark A. T. Blaskovich (ORCID: https://orcid.org/0000-0001-9447-2292)
- Matthew A. Cooper (ORCID: https://orcid.org/0000-0003-3147-3460)
- Minh Duc Cao (ORCID: https://orcid.org/0000-0003-4079-2383)
- Alysha G. Elliott (ORCID: https://orcid.org/0000-0002-2983-0484)
- Soumya Ramu (ORCID: https://orcid.org/0000-0001-5706-4169)
Institutions
- University of Technology Sydney (AU)
- The University of Queensland (AU)
- The University of Melbourne (AU)
- Peter Doherty Institute (AU)
Publication Details
- Journal
- JAC-Antimicrobial Resistance
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1093/jacamr/dlaf108
- Primary Topic
- Antimicrobial Resistance in Staphylococcus
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wellcome Trust
- Medical Research Council
- National Health and Medical Research Council
- Agence de l'innovation de Défense